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Abstract:  An  ultrasensitive  and  renewable  electrochemiluminescence  (ECL)  
immunosensor was developed for the detection of tumor markers by combining a newly 
designed  trace  tag  and  streptavidin-coated  magnetic  particles  (SCMPs).  The  trace  tag 
(RuL@SiO2-Au~RuL-Ab2) was prepared by loading Ru(bpy)3
2+(RuL)-conjuged secondary 
antibodies (RuL-Ab2) on RuL@SiO2 (RuL-doped SiO2) doped Au (RuL@SiO2-Au). To 
fabricate the immunosensor, SCMPs were mixed with biotinylated AFP primary antibody 
(Biotin-Ab1),  AFP,  and  RuL@SiO2-Au~RuL-Ab2  complexes,  then  the  resulting 
SCMP/Biotin-Ab1/AFP/RuL@SiO2-Au~RuL-Ab2  (SBAR)  sandwich-type 
immunocomplexes were absorbed on screen printed carbon electrode (SPCE) for detection. 
The immunocomplexes can be easily washed away from the surface of the SPCE when the 
magnetic  field  was  removed,  which  made  the  immunosensor  reusable.  The  present 
immunosensor showed a wide linear range of 0.05–100 ng mL
–1 for detecting AFP, with a 
low detection limit of 0.02 ng mL
–1 (defined as S/N = 3). The method takes advantage of 
three  properties  of  the  immunosensor:  firstly,  the  RuL@SiO2-Au~RuL-Ab2  composite 
exhibited  dual  amplification  since  SiO2  could  load  large  amount  of  reporter  molecules 
(RuL) for signal amplification. Gold particles could provide a large active surface to load 
more reporter molecules (RuL-Ab2). Accordingly, through the ECL response of RuL and 
tripropylamine (TPA), a strong ECL signal was obtained and an amplification analysis of 
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protein interaction was achieved. Secondly, the sensor is renewable because the sandwich-
type immunocomplexes can be readily absorbed or removed on the SPCE’s surface in a 
magnetic field. Thirdly, the SCMP modified probes can perform the rapid separation and 
purification of signal antibodies in a magnetic field. Thus, the present immunosensor can 
simultaneously  realize  separation,  enrichment  and  determination.  It  showed  potential 
application for the detection of AFP in human sera. 
Keywords:  [Ru(bpy)3]
2+@SiO2-Au;  alpha-fetoprotein;  sandwich-type  immunoreaction; 
screen printed carbon electrode; electrochemiluminescence 
 
1. Introduction 
The clinical analysis of cancer biomarkers is critical to the early diagnosis of cancer and proteomics 
research,  which  will  also  promote  the  understanding  of  cancer  diseases’  related  biological  
processes  [1-3].  Alpha-fetoprotein  (AFP)  is  a  well-known  tumor  marker  related  to  hepatocellular 
carcinoma  (HCC)  [4].  The  average  concentration  of  AFP  in  serum  often  increases  under  cancer 
conditions from 5–20 ng mL
–1 [5]. Thus the development of ultrasensitive detecting methods for trace 
levels  of  AFP  in  human  serum  is  important  for  the  early  diagnosis  of  cancers.  Compared  with 
conventional  immunoassays  such  as  enzyme-linked  immunosorbent  assay  (ELISA)  and 
chemiluminescence immunoassay, the ECL assay not only shows high sensitivity and wide dynamic 
concentration response range, but also is potential and spatially controlled [6-10]. Among various ECL 
systems,  Ru(bpy)3
2+-based  ECL  has  gained  importance  owing  to  its  superior  properties  of  high 
sensitivity and good stability in aqueous solution under moderate conditions [11,12]. Recently, some 
stable  and  sensitive  ECL  biosensors  based  on  Ru(bpy)3
2+  doped  SiO2  nanoparticles  have  been 
intensively  investigated  [13-15].  On  one  hand,  SiO2  nanoparticles  are  considered  a  good  matrix 
because their surfaces are easily functionalized and conjugated to bioactive molecules, which shows 
great potential in bioanalysis. On the other hand, the SiO2 matrices can resist dye molecules coming off 
and this increases their photostability [13,16]. In addition, gold nanoparticles (Au NPs) have gained 
attention in the last years due to the unique structural, electronic, optical, and catalytic properties which 
have made them become very attractive materials for biosensor systems and bioassays [17]. Yuan and 
co-workers  have  proposed  a  novel  sensitive  ECL  immunoassay  with  AFP  antibody  labeled 
RuL@SiO2-Au as probes [18]. However it required complex modification procedures on the electrode. 
Furthermore the sensor cannot be renewed after the immune products are formed on electrode.  
Conventional electrodes, such as glassy carbon electrode (GCE), Au electrode or magnetic carbon 
paste electrode (MCPE), are relatively expensive and bulky. Moreover, they are not convenient to add 
or  remove  the  magnetic  iron on the long cylindrical electrode to attract the magnetic nanoprobes. 
However, amperometric biosensors fabricated with screen printed carbon electrodes (SPCEs) have the 
advantages of integration of electrodes, simple manipulations, low cost and low consumption of sample 
which  can  be  used  for  one  step  determination,  and  then  discarded  [19,20].  Recently,  magnetic 
nanoparticles have also gained increasing interest and have been widely applied in immunoassays [21,22] 
due  to  their  biocompatibility, superparamagnetism and good electron conductivity [23], which can Sensors 2011, 11                                       
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simplify the process of protein immobilization and separation [24]. The magnetic nanoprobes strategy 
developed recently has proven to be a highly sensitive technique for detecting human tumor cells, and is 
especially  well  suited  to  separate  and  at  the  same  time  detect  
low-concentrations  of  proteins  [25,26].  More  importantly,  the  magnetic  probes  can  be  modified and 
removed from the surface by a magnetic field added on the flat bottom of SPCEs. All these steps can 
make the electrode’s surface renewable and simplify the electrode modification steps. Furthermore, if a 
RuL labeled antibody is employed instead of pure antibody to be labeled on RuL@SiO2-Au nanoparticles 
as  probes  (RuL@SiO2-Au~RuL-Ab2),  the  relevant  ECL  signal  could  greatly  improve  due  to  the 
increased number of reporter molecules (RuL) that are modified on the electrode surface. 
Our  present  work  is  motivated  by  the  promising  applications  of  the  SBAR  sandwich-type 
immunocomplexes for ultrasensitive detection of AFP and renewable surface of SPCEs. In this study, 
the streptavidin-coated magnetic particles (SCMP), as supporting material, not only perform the rapid 
separation  and  purification  of  signal  antibody  on  magnetic  field,  but  they  also  enhance  the  fixed 
capacity  of  Biotin-Ab1  to  improve  the  detection  range.  Furthermore,  the  SBAR  sandwich-type 
immunocomplexes  were  readily  immobilized  on  the  working  electrode  of  SPCEs  by  magnets, 
therefore, unlike traditional electrochemical immune sensors, the electrodes do not require complex 
modification  and  cleaning.  In  addition,  the  RuL@SiO2-Au~RuL-Ab2  composite  exhibited  dual 
amplification since SiO2 could adsorb large amount of reporter molecules (RuL) and gold particles 
could provide large active surface to load more reporter molecules (RuL-Ab2). Thus, the SCMP/Biotin-
Ab1/AFP/RuL@SiO2-Au~RuL-Ab2  (SBAR) sandwich-type immunocomplexes were easy to control 
and have strong ECL signals. 
2. Experimental Section  
2.1. Reagents and Materials 
Alpha-fetoprotein antibody (Anti-AFP, 12 mg L
−1) was from Biocell Company (Zhengzhou, China). 
Elecsys AFP Kits were from Roche Diagnostics GmbH. Tris(2,2’-bipyridyl)ruthenium(II) chloride Hex 
hydrate-(Ru(bpy)3Cl2 6H2O) was from Strem Chemicals. Tripropylamine (TPA) was from Tokyo Kasei 
Kogyo Co, Ltd. Gold chloride (HAuCl4), BSA (96~99%) and Triton X-100 (TX-100) were bought 
from  Sinopharm  Chemical  Reagent  Co.Ltd  (Shanghai,  China).  Tetraethylorthosilicate  (TEOS)  and  
3-aminopropyltriethoxysilane  (APTES)  were  from  Aladdin  Chemistry  Co.  Ltd.  Gold  nanoparticles  
(Au-NPs,  ~16  nm  in  diameter)  were  prepared  according  to  the  procedures  reported  by  
Enüstün
 et al. [27]. Phosphate buffered solution (PBS, pH 7.4) was prepared using 0.1 M Na2HPO4, 
0.1 M KH2PO4 and 0.1 M KCl. Blocking buffer solution consisted of a PBS with 3% (w/v) BSA and 
0.05% (v/v) Tween 20. Washing buffer solution consisted of a PBS with 0.1 M NaCl and 0.05% (v/v) 
Tween 20 (PBST). All other chemicals were of analytical grade and all solutions were prepared with 
doubly distilled water. 
2.2. Apparatus 
ECL experiments were carried out using a MPI-B model electrochemiluminescence analyzer (Xi’an 
Remax Electronic Science &Technology Co. Ltd., Xi’an, China) with the voltage of the photomultiplier Sensors 2011, 11                                       
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tube  set  at  800  V  and  initial  potential  =  0.0  V,  high  potential  =  1.2  V,  scan  rate  =  100  mV/s.  
A  three-electrode  system  was  used,  which  consists  of  a  screen  printed  carbon  working  electrode 
(SPCE),  a  carbon  auxiliary  electrode  and  an  Ag/AgCl  reference  electrode  (DropSens  Corporation, 
Spain). A H600 transmission electron microscope (Hitachi, Japan) was employed to characterize the 
nanoparticles.  
2.3. Preparation of RuL@SiO2-Au Nanoparticles 
RuL@SiO2 nanoparticles were prepared according to the literature [16,28]. In brief, to a mixture of 
TX-100  (1.77  mL),  cyclohexane  (7.5  mL),  n-hexanol  (1.8  mL),  0.1  M  Ru(bpy)3
2+  (80  µL), 
tetraethylorthosilicate (TEOS, 100 µL) and water (340 µL) was added NH4OH (60 µL, 25%). The 
mixture was stirred for 24 h, and the generated solid was isolated with acetone, sonicated for 10 min, 
followed by centrifuging and washing with ethanol and water. Then, the orange RuL@SiO2 nanoparticles 
were collected and dried in vacuum oven. To prepare the RuL@SiO2-Au nanoparticles, RuL@SiO2 
nanoparticles  suspension  in  ethanol  (6  mL,  2  mg  mL
−1)  was  mixed  with  APTES  (200  µL)  and 
vigorously stirred for 30 min. The mixture was centrifuged and washed with water and ethanol to 
produce  aminoterminated  RuL@SiO2  nanoparticles.  A  mixture  of  Au-colloid  (2  mL)  and  
APTES-modified RuL@SiO2 suspension (1 mL) was then prepared and shaken for 1 h to let Au NPs 
be  absorbed  by  the  surface  of  the  amino-terminated  RuL@SiO2  nanoparticles.  The  thus generated 
RuL@SiO2-Au nanoparticles were collected by centrifugation, washed with water and suspended in 
water. The schematic graph of the fabrication process of RuL@SiO2 and RuL@SiO2-Au nanoparticles 
was shown in Scheme 1. 
Scheme 1. Schematic illustration of the preparing procedures of RuL@SiO2 nanoparticles 
and RuL@SiO2-Au composite. 
 
2.4. Preparation of RuL@SiO2-Au~RuL-Ab2 and RuL@SiO2-Au~Ab2 (RuL@SiO2-Au Composite 
Nanoparticles Labeled AFP Secondary Antibody)  
The RuL@SiO2-Au~RuL-Ab2 bionanocomposite were prepared according to the literature [17]. In 
brief, a mixture of RuL@SiO2-Au nanoparticles suspension and excess RuL-Ab2 was stirred for 24 h 
at 4 °C. The mixture was centrifuged and washed with water to obtain the RuL@SiO2-Au~RuL-Ab2 
bionanocomposite. The as-prepared bionanocomposite was incubated with BSA to block the unreacted 
and  nonspecific  sites,  and  then  centrifuged  and  washed  with  PBS,  dispersed  in  0.1  M  PBS  
(2 mL, pH 7.4) and stored at 4 °C for further use. The RuL@SiO2-Au~Ab2 bionanocomposite was 
fabricated by using the same procedure, as shown in Scheme 2. Sensors 2011, 11                                       
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Scheme 2. Schematic illustration of the preparing procedures of RuL@SiO2-Au~RuL-Ab2 
and RuL@SiO2-Au~Ab2. 
 
2.5. Preparation of the SBAR Sandwich-Type Immunocomplexes 
The  schematic  of  the  fabrication  process  is  shown  in  Scheme  3.  The  immunocomplexes  were 
prepared as follows: a mixture of Biotin-Ab1 (50 µL), different concentrations of AFP (50 µL) and  
RuL@SiO2-Au~RuL-Ab2 (50 µL) was prepared and held for 10 min at room temperature. After that, 
streptavidin-coated  magnetic  particles  (SMP,  50  µL)  were  added  into  the  mixture,  allowing  the 
RuL@SiO2-Au~RuL-Ab2-AFP-Ab1-Biotin  sandwich  type  immune-complexes  to  be  captured  on  
the  surface  of  magnetic  particles  via  biotin-streptavidin  interaction.  Then  the  sandwich-type 
immunocomplexes were isolated by a magnet, washed with PBST solution three times, dispersed in  
PBS (150 µL, pH 7.4) and stored at 4 °C for ECL tests. 
Scheme  3.  Schematic  illustration  of  the  preparing  procedures  of  SBAR  sandwich-type 
immunocomplexes (design and process). 
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2.6. ECL Measurements 
The three-electrode system and ECL measurement process are shown in Scheme 4. For each test, 
sandwich-type immunocomplex solution (5 µL) prepared with different concentrations of target AFP 
was attached on the cleaned SPCE surface with a NdFeB permanent magnet, ECL measurements were 
then performed in PBS (30 µL, pH 7.4) containing 10
−5 M TPA with a photomultiplier tube voltage of 
800 V. 
Scheme 4. (a) Schematic illustration of three-electrode SPCE system; (b) The process of 
ECL measurements; (c) the ECL measurement system. 
 
 
 
3. Results and Discussion  
3.1. Characterization of RuL@SiO2 and RuL@SiO2-Au Nanoparticles 
In this work, [Ru(bpy)3]
2+-doped silica matrix loaded with Au-NPs, named RuL@ SiO2-Au, was 
prepared as ECL signal amplification labels and immobilization substrates for AFP secondary antibody 
(Ab2). RuL@SiO2 nanoparticles were first fabricated by using the well-established water-in-oil (W/O) Sensors 2011, 11                                       
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microemulsion  method.  Figure  1(A)  shows  the  TEM  image  of  RuL@SiO2  nanoparticles  with  a 
uniform size distribution (~120 nm diameter). Incorporation of RuL
 molecules inside the silica matrix 
protects  them  from  the  surrounding  environment,  increases  photostability  and  provides  signal 
enhancement due to an increasing amount of RuL
 molecules doped per nanoparticle [29]. Furthermore, 
the  ease  of  assembling  functional  groups  such  as  amines,  thiols  and  carboxyls  on  the  surface  of 
[Ru(bpy)3]
2+-doped silica nanoparticles enables their use as ideal amplification labels for bioanalysis 
applications [30]. To immobilize AFP secondary antibody on the RuL@SiO2 matrix, the surface of 
RuL@SiO2 nanoparticles was aminoterminated with APTES and further reacted with Au-NPs. Figure 
1(B) demonstrates that some individual Au-NPs (~16 nm diameter) and cluster-shape Au-NPs were 
successfully  assembled  on  the  surface  of  RuL@SiO2 nanoparticles.  These  attached  Au-NPs  could 
provide a biocompatible, accessible matrix for immobilization of AFP secondary antibody. 
Figure 1. TEM images of (A) RuL@SiO2; (B) RuL@SiO2-Au. 
   
(A)              (B) 
3.2. Optimization of Experimental Conditions 
The ECL behavior of the sandwiched immunoassay was caused by the TPA and Ru(bpy)3
2+. Thus 
TPA plays an important role in enhancement of the ECL signal. Furthermore, the enhanced ECL signal 
was related to the concentration of TPA. As can be seen from Figure 2, the ECL signal increased with 
increasing concentration of TPA. The effective enhancement occurred at the TPA concentration of  
10
−5 M. Thus 0.1 M of PBS containing 10
−5 M TPA was selected for our measurements. 
Figure 2. Effect of the different concentrations of TPA on the ECL intensity. Experimental 
parameters: initial potential = 0.0 V, high potential = 1.2 V, scan rate = 100 mV/s. 
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3.3. ECL Characterization of RuL@SiO2-Au~RuL-Ab2 
Prior to the use of RuL@SiO2-Au~RuL-Ab2 as labels for the preparation of ECL immunosensors, 
we  investigated  the  ECL  performance  of  RuL@SiO2-Au~RuL-Ab2  in  the  presence  of  TPA.  For 
sandwich-type immunosensors, the sensitivity is mainly determined by the sensitivity of the label. In 
this work, the signal of the ECL immunosensor was mainly from the encapsulated RuL
 toward TPA 
oxidation. Since a large number of RuL
 molecules were incorporated into SiO2 nanoparticles, and due 
to  the  intrinsic  good  electrocatalytic  activity  of  RuL
 toward  TPA  oxidation,  we  hypothesized  the 
sensitivity of the ECL immunosensor could be greatly enhanced when RuL@SiO2-Au~RuL-Ab2 was 
used as recognition element of target AFP and signal amplification label. Figure 3 shows the different 
modified electrodes in PBS in the presence of 10
–5 M TPA. It can be seen that only a small ECL 
intensity  change  was  observed  at  the  RuL-Ab2  modified  electrode  (curve  c).  On  the  contrary,  a 
remarkable  ECL  intensity  increase  was  observed  for  the  RuL@SiO2-Au~Ab2  modified  electrode 
(curve  b)  and  the  largest  ECL  intensity  response  occurred  at  the  RuL@SiO2-Au~RuL-Ab2  
modified  electrode  (curve  a).  These  results  indicated  that  a  large  amount  of  RuL
 molecules  were 
incorporated  into  the  silica  matrix  and  RuL-Ab2  could  be  efficiently  captured  on  the  surface  of 
RuL@SiO2-Au nanoparticles. 
Figure 3. ECL-potential curves of, (a) SCMP/Biotin-Ab1/AFP/RuL@SiO2-Au~RuL-Ab2; 
(b) SCMP/Biotin-Ab1/AFP/RuL@SiO2-Au~Ab2; and (c) SCMP/Biotin-Ab1/AFP/RuL-Ab2 
in pH 7.4 PBS containing 10
–5 M TPA. Experimental parameters: initial potential = 0.0 V, 
high potential = 1.2 V, scan rate = 100 mV/s. 
 
3.4. Performance of the ECL Immunosensor 
The  highly  sensitive  label  of  the  SBAR  sandwich-type  immunocomplexes  was  then  used  
to  construct  ECL  immunosensors  for  AFP  detection.  The  double-conjugated  Ru(bpy)3
2+  
sandwich-type  immunocomplexes  named  Biotin-Ab1/AFP/RuL@SiO2-Au~RuL-Ab2  were  formed 
through antigen-antibody interaction in the presence of different concentrations of AFP. They were 
further  interacted  with  streptavidin-coated  magnetic  particles  (SCMP)  and  attached  on  SCPEs  by 
magnet for ECL measurements. Then the ECL response of RuL and TPA was recorded in 0.1 M PBS 
(pH 7.4) containing 10
−5 M TPA. Sensors 2011, 11                                       
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As shown in Figure 4, EI increased with the increasing of AFP concentration ranging from 0.05 to 
100 ng mL
–1. A linear relation between the logarithm of EI and the logarithm of AFP concentration 
was  obtained  [Log  (∆EI)  =  3.3706  +  0.4075  Log  (cAFP/ng  mL
−1)]  with  a  correlation  coefficient  
R = 0.9962. The detection limit was 0.02 ng mL
–1 (3σ). Such a low detection limit is better than those 
of  previously  reported  AFP  immunosensors.  The  comparison  of  results  is  shown  in  Table  1.  The 
improved detection limit may be attributed to two aspects: (1) the high loading level of RuL
 molecules 
into the silica nanoparticles improved the detection limit; (2) the large amount of RuL-Ab2 absorbed 
onto the Au-NPs surface enhanced the access chance of the antibody-antigen interaction, especially 
when the AFP concentration is very low. 
Figure 4. The schematic illustration of the ECL intensity versus the concentration of AFP 
(0.05  to  100  ng  mL
–1)  in  0.1  M  PBS  (pH  7.4)  containing  10
–5  M  TPA.  Insert:  the 
relationship between Log of ∆ECL signal towards log of different AFP concentrations. 
Experimental parameters: initial potential = 0.0 V, high potential=1.2 V, scan rate = 100 mV/s. 
 
Table 1. Comparison of analytical properties of various AFP immunosensors and immunoassays. 
Assay method 
Linear range 
(ng mL
−1) 
LOD  
(ng mL
−1) 
Detection antibody  Reference 
Electrochemistry assay  1.00–500.0  0.8  Au-Alkaline phosphatase-labeled antibody  [31] 
  0.50–80.0  0.25  HRP-antibody  [32] 
Voltammetric ELISA  0.10–200  0.10  HRP-antibody  [33] 
Chemiluminescence  1.0–800  0.23  HRP-antibody  [34] 
Photoelectrochemistry  0.05–50  0.04  Label-free  [35] 
Electrochemiluninescence  0.05–50  0.03  Ru-silica@Au-antibody  [17] 
  0.05–100  0.02  RuL@SiO2-Au-RuL-antibody  This work 
3.5. Specificity for the Detection of AFP 
The selectivity of the immunosensor was also tested by adding possible interfering substances in the 
AFP-mediated sandwich-type immunoreaction. Different immunocomplexes were prepared with AFP 
(10 ng mL
–1) or AFP (10 ng mL
–1) together with the following individual interferent: carcinoembryonic 
antigen (CEA, 10 ng mL
–1), human IgG (HIgG, 1 µg mL
–1), carbohydrate antigen 19-9 (CA19-9, 10 ng Sensors 2011, 11                                       
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mL
–1), human chorionic gonadotropin antigen (HCG, 10 ng mL
–1), BSA (1 µg mL
–1), ascorbic acid (AA, 
1 µg mL
–1), dopamine (DA, 1 µg mL
–1) and L-lysine (LL, 1 µg mL
–1). The interference degree was 
evaluated by comparing the ECL intensity of a mixture of AFP and interfering substance with that of 
AFP alone. As can be seen from Table 1, less than 5% variation of log(EI) responding to 10 ng mL
–1 
AFP was observed in the presence of different interferents (Figure 5), which demonstrated a good 
selectivity of the developed ECL immunosensor for AFP detection. 
Figure  5.  Selectivity  analysis  of  the  ECL  immunosensor  in  the  presence  of  
different  interferents.  The  concentrations  of  the  interferents  were:  CEA  (10  ng  mL
−1),  
HIgG  (1  µg  mL
−1),  CA19-9(10  ng  mL
−1),  HCG  (10  ng  mL
−1),  BSA  (1  µg  mL
−1),  
DA (1 µg mL
−1), L-lysine (1 µg mL
−1). 
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3.6. Determination of AFP in Human Serum Samples 
In order to investigate the possible application of this immunosensor in clinical analysis, recovery 
experiments were performed by standard addition methods in human serum. The experimental results 
were shown in Table 2 and the recovery was in the range from 95% to 110%, which indicated that the 
developed  sensor  might  be  applied  for  the  determination  of  AFP  in  human  serum  for  routine  
clinical diagnosis.  
Table 2. The recovery of the proposed immunosensor in human serum. 
Sample number  Added (/ng mL
−1)  Found (/ng mL
−1)  Recovery (/%) 
1  0.50  0.51 ± 0.02  102.0 
2  1.00  0.97 ± 0.02  97.0 
3  5.00  5.28 ± 0.2  105.6 
4  10.0  9.8 ± 0.3  98.0 
5  50.0  47.6 ± 2.3  95.2 
1 Mean value ± SD of three measurements. 
3.7. Regeneration 
The magnetic probe (SBAR) can be modified and removed from its surface by magnetic field added 
on the flat bottom of SPCEs. All these steps can renew the electrode surface and make the electrode Sensors 2011, 11                                       
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reusable. As Figure 6 showed cyclic voltammetry (CV) curves of different electrodes (a, bare SPCEs;  
b,  the  immunocomplexes  were  immobilized  on  the  working  electrode  of  SPCEs  surface;  
c, after renewing of SPCEs.) in 1 mM K3Fe(CN)6 (0.1 M KCl), well-defined CVs, characteristic of 
diffusion-limited redox processes, are observed at the bare SPCEs [Figure 6(a)]. The peak currents 
decreased  [Figure  6(b)]  after  SBAR  sandwich-type  immunocomplexes  were  immobilized  on  the 
working electrode of SPCEs surface because the immunocomplexes would block the electron transfer. 
After  removing  the  magnet  and  rinsing  the  sensor  with  PBST,  the  currents  was  further  increased 
[Figure 6(c)] almost black to bare SPCEs, due to the bulk of immunocomplexes were rinsed out.  
Figure 6. Cyclic voltammograms performed in 1 mM Fe(CN)6
3− solution (0.1 M KCl) at 
100 mV s
−1 for (a) bare; (b) SBAR sandwich-type immunocomplexes; (c) removing the 
magnet and rinsing with PBST. 
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4. Conclusions  
In  this  paper,  a  magnetic  probe  (SBAR)  consisting  of  streptavidin-coated  magnetic  particles 
(SCMP) and RuL@SiO2-Au~RuL-Ab2 complexes is used to detect AFP as a model protein. SCMP 
were  used  as  supporting  material  for  the  preparation  of  the  sandwich-type  immunocomplexes.  A 
magnetic  separation  step  was  then  used  to  isolate  the  complexes  from  the  unbound  components, 
considerably  reducing  incubation  and  washing  times.  Furthermore,  the  SBAR  sandwich-type 
immunocomplexes can be modified and removed from its surface by magnetic field added on the flat 
bottom of SPCEs, therefore, the electrodes, unlike traditional electrochemical immunosensors, do not 
require complex modification and cleaning steps. In addition, the RuL@SiO2-Au~RuL-Ab2 composite 
exhibited dual amplification since SiO2 could load large amount of reporter molecules (RuL) and gold 
particles  could  provide  large  active  surface  to  load  more reporter molecules (RuL-Ab2). Thus the 
immunosensor  can  simultaneously  realize  separation,  enrichment  and  determination,  with  high 
sensitivity, which would be valuable for clinical immunoassay for AFP in human serum. 
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